Induction of senescence-associated secretory phenotype underlies the therapeutic efficacy of PRC2 inhibition in cancerLiping Chu, Wei Qi|Cell Death and Disease|2022Cited by 38
EZH2 W113C is a gain-of-function mutation in B-cell lymphoma enabling both PRC2 methyltransferase activation and tazemetostat resistanceLiping Chu, Wei Qi|Journal of Biological Chemistry|2023Cited by 18